MedPath

The Qure study: Q-fever fatigue syndrome - response to treatment.

Completed
Conditions
In English: adult patients with Q fever Fatigue Syndrome. In Dutch: volwassenen met het Q-koortsvermoeidheidssyndroom
Registration Number
NL-OMON25227
Lead Sponsor
Radboud University Nijmegen Medical Centre
Brief Summary

Stephan P. Keijmel, Corine E. Delsing, Gijs Bleijenberg, Jos W. M. van der Meer, Rogier T. Donders, Monique Leclercq, Linda M. Kampschreur, Michel van den Berg, Tom Sprong, Marrigje H. Nabuurs-Franssen, Hans Knoop, Chantal P. Bleeker-Rovers; Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial. Clin Infect Dis 2017 cix013. doi: 10.1093/cid/cix013

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

1. Males or non-pregnant, non-lactating females who are 18 years or older;

2. Laboratory-proven acute Q fever since the year 2007 and/or positive serology fitting a past infection with Coxiella burnetii;

Exclusion Criteria

1. Fulfilling criteria for chronic Q fever, namely:

A. IFA IgG fase I ≥ 1024, ≥ 3 months after acute Q fever, and/or;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue severity measured with the Checklist Individual Strength (CIS).
Secondary Outcome Measures
NameTimeMethod
1. Level of functional impairment measured with the Sickness Impact Profile (SIP) total score;<br /><br>2. Level of psychological distress measured with the total score of the Symptom Checklist 90 (SCL90). The SCL90 consists of 90 items scored on a 5-point scale. Scores range from 90 to 450. A low total score reflects high psychological well-being. The SCL-90 is a reliable and valid instrument;<br /><br>3. Coxiella serology and PCR (peripheral blood).
© Copyright 2025. All Rights Reserved by MedPath